These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 388773)

  • 21. The interaction of cyclosporin A with other immunosuppressive agents in dog recipients of renal allografts.
    Homan WP; French ME; Fabre JW; Millard PR; Denton TG; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):287-90. PubMed ID: 6994297
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular components of renal lymph during allograft rejection: effect of immunosuppression.
    Netto IC; Sakai A; Roberts AP; Cockett AT
    Surg Forum; 1973; 24():554-6. PubMed ID: 4618673
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of azathioprine on kidney allograft tolerance induced by rabbit ATG and donor bone marrow in primates.
    Thomas J; Carver M; Cunningham P; Gonder J; McGaley C; Sash C; Thomas F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):472-5. PubMed ID: 3547827
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.
    Jeffery JR; Guttmann RD; Charpentier B
    Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statewide donor pretreatment study.
    Dienst SG
    Transplant Proc; 1977 Sep; 9(3):1597-9. PubMed ID: 331595
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary cadaver kidney transplant survival after donor pretreatment with cyclophosphamide and methylprednisolone.
    Barry JM; Bennett WM
    Transplantation; 1978 Sep; 26(3):202-3. PubMed ID: 360520
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic implications of lymphocyte depletion.
    Johnson HK; Alford RH; Kaplan MP; Taylor A; Walker PJ; Ginn HE; Richie RE
    Proc Clin Dial Transplant Forum; 1973; 3():63-8. PubMed ID: 4619686
    [No Abstract]   [Full Text] [Related]  

  • 30. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The survival of renal allografts in dogs treated with immunosuppressive drugs.
    Rappel R
    J Am Osteopath Assoc; 1967 Jun; 66(10):1133-40. PubMed ID: 4167311
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effect of recipient blood transfusion and donor pretreatment with cyclophosphamide and methylprednisolone.
    Corry RJ; West JC
    Transplant Proc; 1981 Mar; 13(1 Pt 1):161-3. PubMed ID: 7022814
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced renal allograft survival from azathioprine/steroid modified antibody-dependent cellular cytotoxicity.
    Dumble LJ; Macdonald IM; Kincaid-Smith P; Clunie GJ
    Proc Eur Dial Transplant Assoc; 1981; 18():475-80. PubMed ID: 7036169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of leflunomide in the canine renal transplantation model.
    McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
    Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor pretreatment: rat heart allograft survival and measurement of passenger leukocyte depletion with indium-111.
    Oluwole S; Hardy MA; Wang T; Satake K; Todd G; Reemtsma K; Nowygrod R
    Transplantation; 1980 Jul; 30(1):31-3. PubMed ID: 6994282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction and mechanisms of unresponsiveness in a rat renal allograft model after recipient pretreatment with specific antigen and cyclosporin and donor pretreatment with irradiation and cyclophosphamide.
    Müller GH; Greger B; Schareck W; Hopt UT; Lauchart W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):385-7. PubMed ID: 2650155
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.